Echosens Appoints Romain Baujard as Group Chief Executive Office

Echosens, a global diagnostic company specializing in non-invasive medical devices and services, announced the appointment of Romain Baujard as Group Chief Executive Officer, effective May 1, 2026. 

"I am honored to take on this responsibility," said Baujard. "Echosens is at a key turning point as innovation accelerates across cardiometabolic care. Liver assessment is becoming essential to how patients are evaluated and managed. Our opportunity is to embed liver assessment as an integrated part of routine care at scale." 

He added: "We will continue to expand access to our technologies, support clinicians beyond traditional specialties, and advance our digital, data, and AI capabilities to drive earlier detection and more effective risk management."